期刊文献+

阿奇霉素联合辛伐他汀治疗慢阻肺合并肺动脉高压的效果探讨 被引量:3

Effect of azithromycin combined with simvastatin for COPD accompanying pulmonary hypertension
下载PDF
导出
摘要 目的:探讨用阿奇霉素联合辛伐他汀治疗慢性阻塞性肺疾病(简称慢阻肺)合并肺动脉高压的效果。方法:将2016年1月至2017年6月期间四川省成都市龙泉驿区第二人民医院收治的88例慢阻肺合并肺动脉高压患者作为研究对象。将这些研究对象随机分为对照组(n=44)和治疗组(n=44)。为对照组患者使用辛伐他汀分散片进行治疗。为治疗组患者使用阿奇霉素联合辛伐他汀分散片进行治疗。然后,比较两组患者的血氧分压、动脉血二氧化碳分压、肺动脉压、一秒钟用力呼气量及用力肺活量。结果:接受治疗后,治疗组患者的血氧分压及肺动脉压均低于对照组患者,其动脉血二氧化碳分压高于对照组患者,其一秒钟用力呼气量及用力肺活量均大于对照组患者(P<0.05)。结论:用阿奇霉素联合辛伐他汀治疗慢阻肺合并肺动脉高压的效果显著。 Objective:To study effect of azithromycin combined with simvastatin for chronic obstructive pulmonary disease(COPD) accompanying pulmonary hypertension.Methods:Select 88 cases of the patients with COPD accompanying pulmonary hypertension received by The Second People's Hospital of Longquanyi District during January 2016 to June 2017 for research object.Divide the cases to control group(n=44)and experimental group(n=44).Treat control group with simvastatin dispersible tablets,treat experimental group with azithromycin combined with simvastatin dispersible tablets.Then compare Pa O2,Pa CO2,pulmonary artery pressure,FEV1,FVC of 2 groups.Results:After treatment,the Pa O2 and pulmonary artery pressure of experimental group are lower than that in control group,Pa CO2 of experimental group is higher than that in control group,the FEV1 and FVC of experimental group are larger than that in control group(P〈0.05).Conclusion:The effect of azithromycin combined with simvastatin for COPD accompanying pulmonary hypertension is good.
作者 陈晓英 CHEN Xiao ying(The Second People' s Hospital of Longquanyi District, Sichuan, Chengdu 61010)
出处 《当代医药论丛》 2018年第4期32-33,共2页
关键词 慢阻肺 肺动脉高压 阿奇霉素 辛伐他汀 COPD pulmonary artery pressure azithromyein simvastatin
  • 相关文献

参考文献5

二级参考文献66

  • 1葛晓燕.他汀类药物治疗COPD合并PH患者疗效及安全性的荟萃分析[J].医学信息(医学与计算机应用),2014,0(13):124-125. 被引量:3
  • 2中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2007修订版).中华结核和呼吸杂志,2007,30:817-817.
  • 3Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension [ J ]. J Am Coli Cardiol, 2009, 54(1 Suppl) : S43- S54.
  • 4Gall4 N, Hoeper MM, Humbert M, et al. Guidelines for the diag- nosis and treatment of pulmonary hypertension : the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the Eu- ropean Society of Cardiology (ESC) and the European Respiratory Society(ERS). endorsed by the International Society of Heart and Lung Transplantation (ISHLT) [ J ]. Eur Heart J, 2009, 30 (20) : 2493 - 2537.
  • 5McLaughlin W, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert conserlsus document on pulmonary hypertension:a re- port of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Associa- tion : developed in collaboration with the American Collegeof Chest Physicians, American Thoracic Society, Inc. , and the Pulmonary Hypertension Association [ J ]. Circulation, 2009,53 ( 17 ) : 2250 - 2294.
  • 6刘萍,秦兴国.慢性阻塞性肺疾病肺康复综合治疗的研究进展[J].医学临床研究,2015,32(5):983-985.
  • 7Keddissi JI, Younis wG, Chbeir EA, et al. The use of statins and Lung function in current and former smokes[ J]. Chest, 2007, 132 (6) : 1764 -1771.
  • 8RABE KF, HURD S,ANZUETO A, etal. Global strategy for the diagnosis,management,and prevention of chronicobstructive pulmonary disease: GOLDexecutive summary [J]. Am J RespirCrit Care Med, 2007,176(6) :532-555.
  • 9KOSANOVIC D, DAHAL BK, PETERSDM,et al. Histological characte-rizationof mast cell chymase in patients withpulmonary hypertension and chronicobstructive pulmonary disease [J]. PulmCirc, 2014,4⑴:128-136.
  • 10何忠,彭玲.急性加重期COPD患者血清TNF-α、IL-6和CRP变化及意义[J].医学临床研究,2008,25(4):624-625. 被引量:6

共引文献72

同被引文献27

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部